Nuclear Cardiology

Single photon computed tomography (SPECT) and positron emission tomography (PET) molecular imaging are used as primary cardiac imaging modalities to evaluate the function of the heart. It uses radioactive isotopes attached to sugars that are metabolized by cardiomyocytes. This creates an image of the metabolic activity of the heart and shows areas of ischemia or infarct. Other radiotracers can image the heart to diagnosis cardiac amyloidosis and sarcoidosis. 

SNMMI Image of the Year 68Ga-FAPI-46 PET/CT heart attack acute myocardial infarction

‘Image of the Year’ highlights the predictive power of a new PET imaging agent

The Society of Nuclear Medicine and Molecular Imaging has chosen its 2022 Image of the Year, and it’s one that is sure to interest anyone in the field of cardiac imaging.

Siemens debuts new, cleared SPECT/CT model

Siemens Healthineers splashed an FDA-approved SPECT/CT system June 12 at the 2022 annual meeting of the Society of Nuclear Medicine & Nuclear Imaging in Vancouver, B.C.

Thumbnail

Wisconsin company to begin producing medical isotopes next year

The company’s CEO, Greg Piefer, detailed the plans at the Wisconsin Entrepreneurs’ Conference on June 2, stating that production would be achieved via small-scale nuclear transmutation.

The American Society fo Nuclear Cardiology (ASNC) did not support the 2021 Chest Pain Guidelines because of the high support for cardiac CT and FFR-CT.

VIDEO: Why the ASNC did not support the 2021 Chest Pain Evaluation Guidelines

Randall Thompson, MD, immediate past president of the American Society of Nuclear Cardiology, said the group had issues with the document's elevation of cardiac CT and FFR-CT. 

Advnaces in nuclear cardiac imaging include the use of PET, quantitative coronary flow reserve and the additional CT ro SPECT and PERT scans. #ASNC

VIDEO: 2 key advances in cardiac nuclear imaging technology

Randall Thompson, MD, immediate past president of the American Society of Nuclear Cardiology (ASNC), explains two key advances in cardiac nuclear imaging.
 

A comparison on the black hole at the center of the Milky Way galaxy (left) with PET cardiac myocardial perfusion nuclear imaging exams (right).  The cardiac diagnosis of the galactic heart is motion artifact. Black hole image from the EHT Collaboration

Cardiologist and ASNC president diagnoses the heart of the galaxy based on black hole imaging

The first image of the black hole at the heart of our Milky Way galaxy amazed the scientific community, but left cardiologists with questions about the true cardiac health of the galaxy.

A figure from the 2022 CAD non-invasive imaging guidelines showing a comparison of computed tomography angiography (CTA) and a SPECT-CT vs. an invasive angiogram from the cath lab showing the same blockage in a coronary artery.

New multi-society recommendations highlight role of non-invasive imaging in evaluating coronary artery disease

A new, multi-society document, "Non-Invasive Imaging in Coronary Syndromes," focuses on how multiple imaging techniques can evaluate different aspects of coronary artery disease (CAD), all without the need for invasive angiograms.

The ASNC is one of several medical imaging societies asking Congress to repeal the appropriate use criteria (AUC) criteria mandate. They say it poses issues for clinicians and is becoming outdated by changes in CMS payment systems. The AUC requirements call for documentation using CVMS authorized software in order to show advanced imaging such as nuclear and CT is justified, or else Medicare payments might be withheld.

American Society of Nuclear Cardiology urges Congress to speed prior authorizations, repeal AUC mandate 

Over the past few weeks, members of ASNC’s Health Policy Committee have held meetings with their members of Congress.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.